Isopto Carpine

Pilocarpine Hydrochloride, the active ingredient in Isopto Carpine, is a miotic (cholinergic agonist) presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is employed in the management of open‑angle glaucoma and ocular hypertension.

GNH USA supplies Isopto Carpine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory support for ophthalmic therapeutics across global markets. The company ensures product quality through stringent quality‑assurance processes and adheres to EU pharmacopeial standards.

Isopto Carpine, a miotic ophthalmic agent, is used to manage conditions that require reduction of intra‑ocular pressure or pupil constriction.

Open-angle glaucoma: reduces intra‑ocular pressure to slow disease progression. Ocular hypertension: lowers eye pressure to prevent development of glaucoma. Acute angle‑closure glaucoma: promotes miosis to open the angle and improve aqueous outflow. Diagnostic procedures requiring miosis: induces pupil constriction to enhance visualization during eye examinations.

Pilocarpine ophthalmic solution may cause ocular and systemic adverse reactions, which are categorized by frequency.

Common Side Effects: - Blurred vision - Eye irritation or burning sensation - Redness of the conjunctiva - Increased tearing

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis, angioedema) - Persistent myopia or worsening of near vision - Corneal ulceration or keratitis

When prescribing Isopto Carpine, clinicians should observe several safety considerations to minimize risk.

Monitor intra‑ocular pressure: assess response after initiation. Use with caution in patients with asthma or chronic obstructive pulmonary disease: cholinergic stimulation may affect bronchial tone. Avoid in narrow‑angle glaucoma unless specifically indicated: may precipitate angle closure. Caution when combined with anticholinergic medications: may reduce therapeutic effect. Store at room temperature: keep in the original container, protect from light and moisture.

Pilocarpine can interact with other agents that influence cholinergic pathways or ocular physiology.

Major Interactions (Avoid): - Anticholinergic drugs (e.g., atropine, scopolamine): may antagonize pilocarpine’s miotic effect. - Systemic cholinesterase inhibitors (e.g., donepezil, rivastigmine): risk of excessive cholinergic stimulation. - Beta‑blocker ophthalmic solutions used concurrently: additive intra‑ocular pressure reduction may lead to hypotony.

Moderate Interactions (Monitor Closely): - Topical non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase ocular irritation. - Systemic antihistamines: may diminish miotic response. - Cycloplegic agents (e.g., tropicamide): may oppose pupil constriction.